SCHEMBL30397703

SCHEMBL30397703

O=C(NNc1ccccn1)C1COCC(Nc2ncc(C(F)(F)F)c(OC3COC3)n2)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.38
CDK2 P24941 5/20 0.37
CCNE1 P24864 4/20 0.37
CCNK O75909 3/20 0.37
CDK12 Q9NYV4 3/20 0.37
CDK7 P50613 2/20 0.37
CCNH P51946 2/20 0.37
MNAT1 P51948 2/20 0.37
CCNT1 O60563 2/20 0.37
CDK9 P50750 2/20 0.37
MAPK3 P27361 6/20 0.36
MAPK1 P28482 1/20 0.36
KDR P35968 1/20 0.35
P2RX7 Q99572 1/20 0.34
GAA P10253 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PTK2 Q05397 3/20 0.34
PDE10A Q9Y233 1/20 0.34
ATXN2 Q99700 1/20 0.34
ULK1 O75385 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25209416 1.00 GRM5 (0.38) GRM5CDK2CCNE1CCNKCDK12
SCHEMBL25218005 0.82 CDK2 (0.41) CDK2CCNE1CCNKCDK12CDK7
SCHEMBL30397931 0.82 CDK2 (0.41) CDK2CCNE1CCNKCDK12CDK7
SCHEMBL30397298 0.80 CDK2 (0.40) CDK2CCNE1CCNKCDK12CDK7
SCHEMBL25224397 0.80 CDK2 (0.40) CDK2CCNE1CCNKCDK12CDK7
SCHEMBL30397130 0.73 MAPK3 (0.46) CDK2CCNE1CCNKCDK12CDK7
SCHEMBL30397992 0.73 MAPK3 (0.46) CDK2CCNE1CCNKCDK12CDK7
SCHEMBL25530225 0.73 ULK1 (0.37) MAPK3MAPK1PTK2ULK1
SCHEMBL22998319 0.72 ULK1 (0.44) CDK2MAPK3MAPK1KDRPTK2
SCHEMBL25522696 0.71 ULK1 (0.55) CDK2CCNE1CCNKCDK12CDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023091726-A1 INHIBITORS OF CYCLIN‑DEPENDENT KINASE 12 (CDK12) SYROS PHARMACEUTICALS, INC. (US) 2023-05-25 WO disclosed